Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: ampicillin / penicillins / morphine hcl attending: chief complaint: ebv+ cns lymphoma, requiring methotrexate and dialysis. major surgical or invasive procedure: methotrexate dose with leucovorin rescue on cvvh stereotactic biopsy of brain lumbar puncture history of present illness: is a 39-year-old right-handed woman with type i diabetes mellitus, glomerulonephritis and renal/pancreas transplant with ebv-driven cns lymphoma presenting for high-dose iv methotrexate. please see initial history and physical by dr. for admission details. hospital course: the patient was initially admitted to the omed service, but was transferred to icu for cvvh after her high dose methotrexate. her dose was administered at 1:00 a.m. on and she was started on high-flow hemodialysis and then transitioned to cvvh, per renal. she was given leucovorin rescue and bicarbonate. her liver function tests increased following therapy and the leucovorin dose was increased. on , her methotrexate level was < 0.1 um and she was transitioned to the medical floor for disposition planning. she tolerated the treatment well with minimal side effects. currently, she feels well and has no complaints. she is anxious to go home. she denies pain and is breathing comfortably. she has been eating and going to the bathroom normally. she has no rash and no tenderness over her line sites. past medical history: -iddm diagnosed at age 14 months -hypertension -crescentic glomerulonephritis at age 14 which progressed to renal failure, requiring dialysis s/p deceased donor renal transplant c/b graft rejection, s/p second cadaveric renal transplant , and s/p cadaveric kidney/pancreas transplant in , s/p bilateral nephrectomy of her native kidneys due to hypertension, on immunosuppression -s/p ligation of arteriovenous fistula, left antecubital space -ventral/incisional hernias (times 4) s/p repair -anemia -polycystic ovarian syndrome -chronic pancreatitis -renal osteodystrophy oncological history: the patient initially presented with mood changes. she was admitted to for elective ventral hernia repair with mesh and work up of altered mental status. mri brain without gadolinium wiht moderate atrophy and mild periventricular hyperintensities and hydrocephalus. a spinal tap performed on showed 2 wbc, 49 protein, and 72 glucose, but she was positive for ebv pcr in the csf. but hhv-6, hsv1 and 2, and virus pcr were all negative. she was placed on 15 days of iv ganciclovir for meningoencephalitis with positive ebv pcr in csf. a repeat lumbar puncture on yield negative ebv pcr, both qualitative and quantitative, in the csf. but her memory function improved but it was still off. a repeat head mri without gadolinium showed 3 hyperintense flair lesions in the left caudate, right parietal periventricular region, and left frontal region near the surface of the brain. she underwent a stereotaxic brain biopsy by , m.d. on and the pathology showed ebv-driven cns lymphoma. her cyclosporin was taken off subsequently. she still has short-term memory problems and psychomotor slowing. social history: she denies cigarette or illicit drug use. she drinks a glass of wine/month. she has a boyfriend, , but she lives with her sister. she reports that she was in special education classes but is college educated. family history: her grandfather had niddm and her great grandmother apparently had iddm. physical exam: vital signs: temperature 98.0 f, blood pressure 120/80, heart rate 90, respiration 20, oxygen saturation is 100% in room air. skin: full turgor. general: sitting in bed, poor eye-contact, nad : perrl, but with several beats of nystagmus with gaze in both directions, o/p clear neck: supple, no lad, no jvd cardiovascular: rrr no m/g/r pulmonary: ctab no w/r/r abdomen: soft, non-distended, and non-tender, with normoactive bowel sounds extremities: no c/c/e, fistula in lue, no palpable thrill neurological examination: her karnofsky performance score is 60. she is awake, alert, and oriented times 3. her language is fluent with good comprehension. her recent recall is good. cranial nerve examination: her pupils are equal and reactive to light, 3 mm to 2 mm bilaterally. extraocular movements are full. visual fields are full to confrontation. funduscopic examination reveals sharp disks margins bilaterally. her face is symmetric. facial sensation is intact bilaterally. her hearing is intact bilaterally. her tongue is midline. palate goes up in the midline. sternocleidomastoids and upper trapezius are strong. motor examination: she does not have a drift. her muscle strengths are at all muscle groups. her muscle tone is normal. her reflexes are 2- and symmetric bilaterally. her ankle jerks are absent. her right toe is down but the left one is up. sensory examination is intact to touch and proprioception. coordination examination does not reveal dysmetria. her gait is normal. she can do tandem. she does not have a romberg. pertinent results: 03:30pm (csf) wbc-6 rbc-1* polys-0 lymphs-92 monos-0 macrophag-8 (csf) protein-61* glucose-56 ld(ldh)-15 04:27pm wbc-8.9 rbc-3.06* hgb-9.5* hct-29.5* mcv-96 mch-31.1 mchc-32.3 rdw-15.6* glucose-86 urea n-68* creat-2.6* sodium-141 potassium-5.0 chloride-108 total co2-15* anion gap-23* alt(sgpt)-52* ast(sgot)-52* ld(ldh)-310* alk phos-80 tot bili-0.4 pt-12.5 ptt-26.9 inr(pt)-1.1 pet-ct () focal increased uptake in known right parietal (suvmax 5.0) and left basal ganglia lesions (suvmax 6.8). there is no fdg avid disease outside the brain. mri: impression: limited study, performed without contrast enhancement, due to the patient's significant renal insufficiency, with: 1. normal spinal cord caliber and intrinsic signal intensity, through the level of the conus medullaris. 2. no discrete epidural or paraspinal soft tissue mass. 3. normal vertebral height and alignment, with heterogeneous intrinsic signal intensity, which may represent red marrow reconversion and/or response to chemotherapy, but should be correlated clinically. there is no focal stir-signal abnormality to specifically suggest marrow replacement. comment: though there is a grossly normal appearance to the conus medullaris and distribution of cauda equina nerve roots, leptomeningeal, nerve root, and, even, intramedullary tumor involvement cannot be the excluded in the absence of intravenous contrast. labs at discharge: lumbar puncture: many lymphocytes with rare atypical forms and monocytes present. clonality could not be assessed in this case due to insufficient numbers of b cells. cell marker analysis was attempted, but was non-diagnostic in this case due to insufficient numbers of cells. wbc rbc hct mcv mch mchc rdw plt 5.7 2.20* 27.2 95 31.0 32.5 15.3 321 glucose urean creat na k cl hco3 angap 126* 27* 2.4* 137 4.2 108 21* 12 alt ast alkphos totbili 204* 123* 62 0.2 calcium phos mg 8.2* 3.0 1.5* brief hospital course: (1) ebv-derived cns lymphoma: identified by biopsy. she is being treated per plan by drs. and . patient received iv high-dose methotrexate, and leucovorin rescue was started on the onc floor; patient received cvvh after hd was done on the floor. leucovorin rescue was continued per heme/onc orders and bicarbonate per heme/onc orders. per renal, discontinued bicarbonate on day of transfer. leucovorin was then increased per onc recs. upon discharge, vna services will flush dialysis line with saline and heparin. patient will then have continued line care during subsequent scheduled admissions. (2) encephalopathy: some of her neurological impairment was thought to be due to residual effects of ebv meningoencephalitis, but outpatient note suggested more likely to be lymphoma effects. dr. outpatient note suggests prominent features are memory impairment and emotional lability. dr. suggested methylphenidate as a possible aid to improved cognition. her encephalopathy did not progress and remained at baseline throughout her stay. (3) s/p pancreas-kidney double transplant: transplanted kidney had marginal function. estimated creatinine clearance has been 20-25 cc/min/m2. diabetes no longer an issue. we held cellcept during course, which was restarted upon discharge. other anti-rejection meds were continued, including prednisone. (4) hypertension: this was reasonably controlled during admission on atenolol 100 daily and amlodipine 5mg daily. (5) full code. medications on admission: amlodipine - 5 mg tablet - 1 tablet(s) by mouth daily (daily) aranesp sureclick -polysorbate - 100 mcg/0.5 ml pen injector - im/subq weekly atenolol - (update) - 100 mg tablet - 1 tablet(s) by mouth once a day atorvastatin - 10 mg tablet - 1 tablet(s) by mouth once a day calcitriol - 0.25 mcg capsule - 1 capsule(s) by mouth once a day ergocalciferol (vitamin d2) - 50,000 unit capsule - 1 capsule(s) by mouth qweek x 3 months folic acid - (dose adjustment - no new rx) - 1 mg tablet - 1 tablet(s) by mouth once a day furosemide - (prescribed by other provider) - 20 mg tablet - 1 (one) tablet(s) by mouth as needed mycophenolate mofetil - 500 mg tablet - 2 tablet(s) by mouth twice a day pantoprazole - (prescribed by other provider: . - 40 mg tablet, delayed release (e.c.) - 1 tablet(s) by mouth once a day picc line - - please discontinue picc line once prednisone - 1 mg tablet - 4 tablet(s) by mouth once a day sevelamer hcl - (prescribed by other provider) - 400 mg tablet - 2 tablet(s) by mouth three times a day medications - otc ferrous sulfate - (prescribed by other provider) - 325 mg (65 mg iron) tablet - 1 tablet(s) by mouth daily (daily) sodium bicarbonate - (dose adjustment - no new rx) - 650 mg tablet - 3 tablet(s) by mouth twice a day only taking 1300mg qd discharge medications: 1. amlodipine 5 mg tablet sig: one (1) tablet po daily (daily). 2. atenolol 50 mg tablet sig: two (2) tablet po daily (daily). 3. atorvastatin 10 mg tablet sig: one (1) tablet po daily (daily). 4. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 5. cellcept mg tablet sig: one (1) tablet po twice a day. 6. sodium bicarbonate 650 mg tablet sig: three (3) tablet po twice a day. disp:*180 tablet(s)* refills:*2* 7. prednisone 1 mg tablet sig: four (4) tablet po daily (daily). 8. calcitriol 0.25 mcg capsule sig: one (1) capsule po once a day. 9. vitamin d 50,000 unit capsule sig: one (1) capsule po once a week. 10. folic acid 1 mg tablet sig: one (1) tablet po once a day. 11. lasix 20 mg tablet sig: one (1) tablet po once a day as needed for swelling. 12. renagel 400 mg tablet sig: three (3) tablet po three times a day. 13. ferrous sulfate 325 mg (65 mg iron) tablet sig: one (1) tablet po once a day. 14. lorazepam 1 mg tablet sig: one (1) tablet po at bedtime as needed for anxiety. disp:*30 tablet(s)* refills:*0* discharge disposition: home with service facility: vna southeastern mass discharge diagnosis: cns lymphoma chronic renal insufficiency s/p renal transplant discharge condition: stable, methotrexate level < 0.1 um, creatinine:1.0 discharge instructions: you came to the hospital for chemotherapy treatment. you required dialysis while getting this treatment. you tolerated your treatment well, without complication. we made the following changes to your medications: start taking leucovorin 60 mg q4h if you have fever, chills, nausea, vomiting, diarrhea, chest pain, shortness of breath, swelling in your legs, headache, confusion, slurred speech or any other symptoms that are concerning to you please call your doctor or come to the emergency room. please keep all your appointments as below. **please keep your catheter dressing dry, no showers. baths are fine, just please keep the dressing dry. a wet dressing increases the risk of infection** followup instructions: , m.d. phone: date/time: 1:30 , md phone: date/time: 10:10 please call and f/u with liver clinic within 1 month: procedure: venous catheterization, not elsewhere classified hemodialysis venous catheterization for renal dialysis injection or infusion of cancer chemotherapeutic substance diagnoses: pure hypercholesterolemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified other encephalopathy kidney replaced by transplant pancreas replaced by transplant encounter for antineoplastic chemotherapy primary central nervous system lymphoma, unspecified site, extranodal and solid organ sites 

Answer: The patient is high likely exposed to